Literature DB >> 2481994

Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.

M Phillips1, B L Deyoe, P C Canning.   

Abstract

Monoclonal antibodies recognizing the O-polysaccharide portion of Brucella abortus strain 2308 provided BALB/c mice with passive protection against challenge exposure with the homologous strain. Numbers of colony-forming organisms in the spleen were reduced by IgM and IgG monoclonal antibodies. Active immunization of mice, using B abortus 2308S lipopolysaccharide, resulted in production of IgM antibody at 14 days. Clearance of organisms in the actively immunized mice after challenge exposure at 14 days was nearly identical to that in passively immunized mice. Mice either passively or actively immunized were effectively protected from 0 to 28 days. Bacterial colonization of the spleen was observed to increase in both groups of mice at 56 days and indicated that humoral responses were effective in eliminating the organism in the early stages of infection, but other immune mechanisms were necessary for protection of mice in the later stage of infection with virulent strains of B abortus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481994

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  19 in total

1.  Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis.

Authors:  N F Cheville; S C Olsen; A E Jensen; M G Stevens; A M Florance; H S Houng; E S Drazek; R L Warren; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Determination of stability of Brucella abortus RB51 by use of genomic fingerprint, oxidative metabolism, and colonial morphology and differentiation of strain RB51 from B. abortus isolates from bison and elk.

Authors:  A E Jensen; D R Ewalt; N F Cheville; C O Thoen; J B Payeur
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

Authors:  Paul de Figueiredo; Thomas A Ficht; Allison Rice-Ficht; Carlos A Rossetti; L Garry Adams
Journal:  Am J Pathol       Date:  2015-04-17       Impact factor: 4.307

4.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19.

Authors:  M G Stevens; S C Olsen; G W Pugh
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  A Cloeckaert; V Weynants; J Godfroid; J M Verger; M Grayon; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides.

Authors:  A Cloeckaert; I Jacques; P de Wergifosse; G Dubray; J N Limet
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.